THE DELIVERY PLATFORM
Lyoprester SS™: two chambers, one single shot
Lyoprester SS™ is the single-shot member of Panacea Bio Chem’s Lyoprester platform ↗— the proprietary approach to preserving sensitive biological materials through controlled lyophilisation and cartridge-based delivery. It exists to solve a specific problem created by the Rethiamine concept: how to keep a peptide and a vitamin apart during storage, yet deliver them together in one rapid reconstitution.
The answer is physical separation at two levels. Between the layers, the dual-layer Peptourbillon™ keeps retatrutide and thiamine in distinct strata of one cake. Between solid and liquid, the two-chamber layout keeps the dry cake and the P-EARLs™ vehicle apart until the moment of use.
Protected lyophilised formulation chamber
The first chamber holds the dual-layer cake under vacuum and a controlled inert-gas environment, isolated from moisture, oxygen and the liquid vehicle until activation.
Separate 0.5 mL P-EARLs™ liquid chamber
The second chamber stores the 0.5 mL P-EARLs™ reconstitution vehicle apart from the cake for the entire shelf life of the product concept.
Activation only immediately before use
The vehicle meets the dual-layer cake only at the moment of activation — the architecture avoids long-term storage of retatrutide and thiamine as one ready-mixed liquid.
Why this architecture matters for Rethiamine
- Retatrutide lower layer and thiamine upper layer arranged as a dual-layer Peptourbillon™
- Co-lyophilisation with spatial separation of the two active-containing layers
- Vacuum and controlled inert-gas environment protecting the lyophilised cake
- Formulation-specific reconstitution vehicle designed to reconcile pH-, pI-, ionic-strength- and solubility-related conflicts
- 0.5 mL intended final reconstitution volume
- Single-shot delivery architecture — one weekly administration concept
Reconciliation of pH-, pI-, ionic-strength- and solubility-related conflicts is an engineering objective under evaluation within the development programme. ArgonLock™, OxyDeplete™ and RedoxVault™ atmosphere- and oxidation-management systems are candidate technologies under evaluation for the final system — their use has not been locked into the formulation specification.